Viewing Study NCT05165433

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:40 AM
Ignite Modification Date: 2026-05-18 @ 2:11 PM
Study NCT ID: NCT05165433
Status: COMPLETED
Last Update Posted: 2025-12-16
First Post: 2021-12-07
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY)
Sponsor: Akamis Bio
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epithelial Tumor View
None Metastatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NG-350A View
None Pembrolizumab View
None Akamis Bio Ltd View
None PsiOxus View
None Merck View